| Name | Cvs Pharmacy #00736 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 199 Great Rd, Bedford, Massachusetts 01730 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (718) 275-3607 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Ageing and a low life expectancy are caused, at least partly, by oxidative stress. A team of researchers led by Prof. Dr. Ivana Ivanovi-Burmazovi from the Chair of Bioinorganic Chemistry at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), together with researchers from the USA, have discovered that zinc can activate an organic molecule, helping to protect against oxidative stress.
Nine days after a major earthquake struck, "deeply needed aid streamed into Haiti's ravaged capital in quantities that relief agencies said is a clear sign of progress," the Miami Herald reports.
Human Genome Sciences has reported results at Week 12 following the completion of therapy (SVR12) in a Phase 2b clinical trial of Albuferon(R) (albinterferon alfa-2b) in combination with ribavirin in patients with genotype 1 chronic hepatitis C who are naive to interferon alpha-based treatment regimens.
Two Hershey, Pa., researchers were part of a team that has uncovered what may be an important genetic risk factor for amyotrophic lateral sclerosis (ALS).
Optivus Proton Therapy has announced that Belgium-based IBA has agreed to pay $1.25 million to settle a lawsuit alleging IBA infringed on three Optivus proton therapy patents.
› Verified 3 days ago
| NPI Number | 1356440713 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY #00736 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 199 Great Rd, Bedford, MA 01730 |
| Phone Number | 781-275-3606 |
News Archive
Ageing and a low life expectancy are caused, at least partly, by oxidative stress. A team of researchers led by Prof. Dr. Ivana Ivanovi-Burmazovi from the Chair of Bioinorganic Chemistry at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), together with researchers from the USA, have discovered that zinc can activate an organic molecule, helping to protect against oxidative stress.
Nine days after a major earthquake struck, "deeply needed aid streamed into Haiti's ravaged capital in quantities that relief agencies said is a clear sign of progress," the Miami Herald reports.
Human Genome Sciences has reported results at Week 12 following the completion of therapy (SVR12) in a Phase 2b clinical trial of Albuferon(R) (albinterferon alfa-2b) in combination with ribavirin in patients with genotype 1 chronic hepatitis C who are naive to interferon alpha-based treatment regimens.
Two Hershey, Pa., researchers were part of a team that has uncovered what may be an important genetic risk factor for amyotrophic lateral sclerosis (ALS).
Optivus Proton Therapy has announced that Belgium-based IBA has agreed to pay $1.25 million to settle a lawsuit alleging IBA infringed on three Optivus proton therapy patents.
› Verified 3 days ago
News Archive
Ageing and a low life expectancy are caused, at least partly, by oxidative stress. A team of researchers led by Prof. Dr. Ivana Ivanovi-Burmazovi from the Chair of Bioinorganic Chemistry at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), together with researchers from the USA, have discovered that zinc can activate an organic molecule, helping to protect against oxidative stress.
Nine days after a major earthquake struck, "deeply needed aid streamed into Haiti's ravaged capital in quantities that relief agencies said is a clear sign of progress," the Miami Herald reports.
Human Genome Sciences has reported results at Week 12 following the completion of therapy (SVR12) in a Phase 2b clinical trial of Albuferon(R) (albinterferon alfa-2b) in combination with ribavirin in patients with genotype 1 chronic hepatitis C who are naive to interferon alpha-based treatment regimens.
Two Hershey, Pa., researchers were part of a team that has uncovered what may be an important genetic risk factor for amyotrophic lateral sclerosis (ALS).
Optivus Proton Therapy has announced that Belgium-based IBA has agreed to pay $1.25 million to settle a lawsuit alleging IBA infringed on three Optivus proton therapy patents.
› Verified 3 days ago
Cvs Pharmacy #00736 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 199 Great Rd, Bedford, Massachusetts 01730 Phone: (718) 275-3607 | |
Stop & Shop Pharmacy #88 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 337 Great Rd, Bedford, Massachusetts 01730 Phone: (781) 271-9403 |